Ebola Outbreak in Uganda Death Toll Reaches 177 Global Health Stocks and Travel Sector Await Impact AI May Accelerate Drug Discovery for Brain Conditions Like MND Pet Supplies Retailer Files for Chapter 11 Bankruptcy Amid Industry Challenges American Kidney Fund Expands Kidney Health Coach Program with New Focus on CKM Syndrome Telecom Stocks Rally Ahead of SpaceX IPO Rally Under Scrutiny Anthropic and Microsoft in Talks for AI Chip Deal Following 5 Billion Investment Vivani Medical VANI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction Federated Hermes Inc FHI Q1 2026 Earnings EPS Beats Estimates as Asset Manager Delivers 63 Surprise ITGR Q1 2026 Earnings Slight EPS Miss Amid Operational Execution PCG Q1 2026 Earnings EPS Surges 187 Above Consensus Amid Utility Operational Gains NWFL Q1 2026 Earnings Strong EPS Beat Amid Challenging Environment MVB Financial Corp Q1 2026 Earnings Earnings Beat Expectations Amid Revenue Uncertainty Hercules Capital Notes HCXY Edge Higher Yield and Stability in Focus Profusa Inc PFSA Edges Higher Testing Key Resistance at 040 ADMA Biologics Slides 109 Key Support Levels in Focus Amid Biotech Headwinds ZOOZ Strategy Ltd Warrant ZOOZW Surges 5789 as Speculative Interest Builds Grupo Televisa TV Gains 108 as Shares Test MidRange Support Lucid Motors Speculated as Potential Robotaxi Player KTCC Q1 2026 Earnings Negative EPS Highlights Ongoing Operational Challenges Versant Media Group VSNT Slips Marginally as Shares Consolidate Near Key Support LEXX Q1 2026 Earnings Narrower Loss Surprises as Bioscience Firm Advances Drug Delivery Pipeline Perfect Corp PERF Q1 2026 Earnings EPS Surpasses Estimates Shares Rise Edgewell Personal Care EPC Q1 2026 Earnings EPS Misses Estimates but Shares Gain FTI Q1 2026 Earnings EPS Surges Past Estimates Despite Stock Dip AG Q1 2026 Earnings Silver Miner Misses EPS Estimates as Costs Weigh on Profitability MGRB Q1 2026 Earnings Earnings Beat Estimates Amidst Modest Stock Decline Ovid Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Cash Discipline